CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftmen but cyclosporine A is still required to reduce GVHD and morbidity

S. J. Noga; G. B. Vogelsang; A. Seber; J. M. Davis; K. Schepers; A. D. Hess; R. J. Jones

doi:10.1016/S0041-1345(96)00442-3

CD34⁺ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftmen but cyclosporine A is still required to reduce GVHD and morbidity

S. J. Noga, G. B. Vogelsang, A. Seber, J. M. Davis, K. Schepers, A. D. Hess, R. J. Jones

School of Medicine

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	728-732
Number of pages	5
Journal	Transplantation proceedings
Volume	29
Issue number	1-2
DOIs	https://doi.org/10.1016/S0041-1345(96)00442-3
State	Published - 1997

ASJC Scopus subject areas

Surgery
Transplantation

Access to Document

10.1016/S0041-1345(96)00442-3

Cite this

@article{a34d6abf61ff4ef8ba88ba8f54bdc9cd,

title = "CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftmen but cyclosporine A is still required to reduce GVHD and morbidity",

author = "Noga, {S. J.} and Vogelsang, {G. B.} and A. Seber and Davis, {J. M.} and K. Schepers and Hess, {A. D.} and Jones, {R. J.}",

note = "Funding Information: From the Johns Hopkins Bone Marrow Transplantation Unit, Baltimore, Maryland, USA. Supported by Grants CA 67787 and CA 15396 from the National Institutes of Health. Address reprint requests to Stephen J. Noga, MD, PhD, Room 3-121 Oncology Center, 600 N Wolfe Street, Baltimore, MD 21287.",

year = "1997",

doi = "10.1016/S0041-1345(96)00442-3",

language = "English (US)",

volume = "29",

pages = "728--732",

journal = "Transplantation proceedings",

issn = "0041-1345",

publisher = "Elsevier Inc.",

number = "1-2",

}

TY - JOUR

T1 - CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftmen but cyclosporine A is still required to reduce GVHD and morbidity

AU - Noga, S. J.

AU - Vogelsang, G. B.

AU - Seber, A.

AU - Davis, J. M.

AU - Schepers, K.

AU - Hess, A. D.

AU - Jones, R. J.

N1 - Funding Information: From the Johns Hopkins Bone Marrow Transplantation Unit, Baltimore, Maryland, USA. Supported by Grants CA 67787 and CA 15396 from the National Institutes of Health. Address reprint requests to Stephen J. Noga, MD, PhD, Room 3-121 Oncology Center, 600 N Wolfe Street, Baltimore, MD 21287.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0030944194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030944194&partnerID=8YFLogxK

U2 - 10.1016/S0041-1345(96)00442-3

DO - 10.1016/S0041-1345(96)00442-3

M3 - Article

C2 - 9123500

AN - SCOPUS:0030944194

SN - 0041-1345

VL - 29

SP - 728

EP - 732

JO - Transplantation proceedings

JF - Transplantation proceedings

IS - 1-2

ER -

CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftmen but cyclosporine A is still required to reduce GVHD and morbidity

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

CD34⁺ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftmen but cyclosporine A is still required to reduce GVHD and morbidity